Brilinta 90 mg Tikagrelor Tablets in Pakistan | ZarqTraders.com

Product Description

Brilinta 90 mg (Ticagrelor) Tablets is a prescription antiplatelet medicine used to help reduce the risk of serious cardiovascular events in certain patients. Its active ingredient, ticagrelor, works by preventing platelets in the blood from sticking together too easily, which helps reduce the formation of harmful blood clots.

Brilinta may be prescribed for patients with acute coronary syndrome (ACS) or a history of heart attack, depending on their medical condition and treatment plan. It may also be used in other approved circumstances under specialist supervision.

For people looking for information about Brilinta 90 mg in Pakistan, ZarqTraders.com can be referenced for product-related enquiries. Availability, pricing, packaging, and applicable registration requirements should be confirmed before purchasing.

Important Product Details

• Product Name: Brilinta 90 mg Tablets

• Generic Name: Ticagrelor

• Strength: 90 mg per tablet

• Dosage Form: Oral tablet

• Medicine Category: Antiplatelet agent

• Manufacturer/Brand Owner: AstraZeneca

• Route of Administration: Oral

• Prescription Requirement: Yes

• Primary Purpose: Prevention of certain blood-clot-related cardiovascular events in eligible patients

What Is Brilinta 90 mg Used For?

Brilinta is prescribed to reduce the risk of cardiovascular death, heart attack, and stroke in eligible patients with acute coronary syndrome or a previous heart attack. It can also reduce the risk of stent thrombosis in certain patients who have undergone coronary stent placement.

Ticagrelor works by blocking the P2Y12 receptor on platelets. This reduces platelet activation and aggregation, helping prevent dangerous clots from forming inside blood vessels.

The medicine is often prescribed alongside low-dose aspirin, but the combination and duration of treatment must be determined by the treating clinician.

Key Benefits

When used for an appropriate medical indication, Brilinta may:

• Help reduce the risk of another heart attack in eligible patients.

• Lower the risk of certain cardiovascular complications.

• Help prevent blood clots associated with coronary stents.

• Reduce platelet aggregation and clot formation.

• Support a prescribed cardiovascular treatment plan.

Benefits depend on the patient's diagnosis, medical history, and adherence to the prescribed treatment.

Possible Side Effects and Important Precautions

The most important risk associated with Brilinta is bleeding, which can occasionally be serious or life-threatening. Other possible side effects include shortness of breath, easy bruising, nosebleeds, and gastrointestinal bleeding.

Inform your doctor if you have a history of bleeding, previous bleeding inside the brain, liver problems, or upcoming surgery. Tell your healthcare professional about all medicines and supplements you take, particularly aspirin, anticoagulants, and other antiplatelet medicines.

Do not stop taking Brilinta without medical advice. Stopping it prematurely can increase the risk of serious cardiovascular events, especially after coronary stent placement.

Seek urgent medical attention for uncontrolled bleeding, vomiting blood, black stools, or sudden severe headache.

Storage Instructions

Store Brilinta according to the manufacturer's package instructions. Keep tablets in their original packaging, protected from moisture and excessive heat, and away from children. Check the expiry date before use.

Brilinta 90 mg in Pakistan

For product information and availability enquiries, visit ZarqTraders.com. Before purchasing, confirm the product's authenticity and registration status with a licensed pharmacy or healthcare professional.

Medical Disclaimer: This description is for educational purposes only and does not replace the official patient leaflet or professional medical advice. Brilinta is a prescription medicine and should be taken only as directed by a qualified healthcare professional.